Harrison, M. R., Jeraj, R., Perlman, S., Vanderhoek, M., Kolesar, J., Eickhoff, J., … Liu, G. (2008). Use of VEGF Tyrosine Kinase Inhibitor Withdrawal to Enhance Cytotoxic Chemotherapy Effect in Prostate Cancer. Presented at the Prostate Cancer Foundation Scientific Retreat, Incline Village, NV.

Harrison, M. R., R. Jeraj, S. Perlman, M. Vanderhoek, J. Kolesar, J. Eickhoff, D. Alberti, G. Wilding, and G. Liu. “Use of VEGF Tyrosine Kinase Inhibitor Withdrawal to Enhance Cytotoxic Chemotherapy Effect in Prostate Cancer,” 2008.

Harrison MR, Jeraj R, Perlman S, Vanderhoek M, Kolesar J, Eickhoff J, et al. Use of VEGF Tyrosine Kinase Inhibitor Withdrawal to Enhance Cytotoxic Chemotherapy Effect in Prostate Cancer. In 2008.

Harrison, M. R., et al. Use of VEGF Tyrosine Kinase Inhibitor Withdrawal to Enhance Cytotoxic Chemotherapy Effect in Prostate Cancer. 2008.

Harrison MR, Jeraj R, Perlman S, Vanderhoek M, Kolesar J, Eickhoff J, Alberti D, Wilding G, Liu G. Use of VEGF Tyrosine Kinase Inhibitor Withdrawal to Enhance Cytotoxic Chemotherapy Effect in Prostate Cancer. 2008.